Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.1%

2 terminated out of 22 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

23%

5 trials in Phase 3/4

Results Transparency

33%

4 of 12 completed with results

Key Signals

4 with results86% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (4)
P 3 (5)

Trial Status

Completed12
Unknown4
Recruiting2
Terminated2
Enrolling By Invitation1
Not Yet Recruiting1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT06996834Not ApplicableRecruiting

Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia

NCT03379402Completed

Sepsis-3 Study in Northeast Thailand

NCT07070284Enrolling By Invitation

ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly PatientsAcquired Pneumonia (sCAP) in Elderly Patients"

NCT00475930Not ApplicableCompleted

Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates

NCT03924934Completed

Community-associated Highly-Resistant Enterobacterales

NCT06103500Not ApplicableRecruiting

Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis

NCT06613659Not Yet RecruitingPrimary

Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine

NCT02946775CompletedPrimary

Community Acquired Bacteremic Syndromes in Young Nigerian Children

NCT05047549Unknown

Community-based RSV Surveillance in Infant Mortality: Minimally Invasive Tissue Sampling Study in Karachi, Pakistan

NCT04348734CompletedPrimary

Management of Parapneumonic Pleurisy Guided by an Early Pleural Ultrasound

NCT02531438Phase 3Completed

Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)

NCT03655548Completed

Optimization Management Study of Community Urinary Tract Infections Spectrum

NCT03185923Phase 3UnknownPrimary

Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe Pneumonia

NCT03093220Unknown

Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis

NCT03064464UnknownPrimary

CA-MRSA Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome

NCT01110421Phase 3Terminated

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia

NCT00081575Phase 3CompletedPrimary

Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia

NCT01396798CompletedPrimary

Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in the Paediatric A&E.

NCT01606631CompletedPrimary

Role of Beta-blockers in the Prevention on the Arisen of a Severe Sepsis (TESS)

NCT01563315CompletedPrimary

Community-acquired Pneumonia in Buskerud County in Norway

Scroll to load more

Research Network

Activity Timeline